Inmunoterapia en Hematología

Graduate and Doctorate in Medicine and Surgery from the UAB Consultant Assistant Doctor. Hospital del Mar. IMIM Associate Professor of the Faculty of Medicine UAB/UPF

JM Sancho completed his MD at the University of Navarra in 1992, and a residency in Haematology at the Germans Trias i Pujol Hospital in Barcelona. Dr Sancho focused his research in lymphoproliferative disorders, achieving a PhD from the Universitat Autonoma of Barcelona. He is specialist in Hematology-Hemotherapy, Germans Trias i Pujol University Hospital, Badalona. Dr.Sancho is coordinator of the Clinical Hematology Department of the Catalan Institute of Oncology (ICO) and works in the Deparment of Haematology at the Germans Trias I Pujol University Hospital in Badalona, Spain. Also, he is Principal Investigator at the Josep Carreras Leukaemia Research Institute in the grup of Lymphoid Neoplasms. He will contribute to the data base elaboration and will supervise clinical aspects of the project. He is author or co-author of articles and books’ chapters about lymphomas, ALL and stem cell transplantation. Dr. Sancho is the principal investigator in many phases I to IV clinical trials on lymphoproliferative disorders. He is member of the Spanish Society of Haematology (SEHH) and Spanish Lymphoma Group (GELTAMO).

Pau Abrisqueta is a hematologist and Head of the Lymphoma Unit at Vall d’Hebron University Hospital, where he also leads the Hematology Clinical Trials Unit within the Vall d’Hebron Institute of Oncology (VHIO). He obtained his Medical Degree from the University of Barcelona in 2003 and completed his residency in Hematology at Hospital Clínic de Barcelona.

Laura Magnano is a senior specialist in the Haematology Service of the Hospital Clínic de Barcelona and an IDIBAPS accredited researcher. After completing her medical studies at the National University of Córdoba, Argentina, she first specialised in internal medicine and from 2010 to 2014 completed her residency in haematology and haemotherapy at the Hospital Clínic de Barcelona. Subsequently, she pursued doctoral studies at the University of Barcelona, on clinical-biological factors related to the microenvironment, histological transformation and response to treatment in patients with follicular lymphoma obtaining the extraordinary doctoral award for the academic year 2018-2019. Her areas of interest are lymphoproliferative syndromes, lymphoproliferative syndromes and lymphocytic lymphoma.

Alberto Mussetti is Director of the Stem Cell Transplantation and Cellular Therapy Unit at the Catalan Institute of Oncology (ICO) – Hospital Duran i Reynals, where he oversees hematopoietic stem cell transplantation and CAR-T cell therapy programs in both clinical and commercial settings.

Dr. Sánchez is Head of the Lymphoma Unit at Hospital del Mar, where she leads clinical care, translational research, and innovation projects focused on lymphoid malignancies. Her work combines patient care with research initiatives aimed at improving the biological understanding and treatment of lymphoma.